<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="58507">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02344368</url>
  </required_header>
  <id_info>
    <org_study_id>2014/2089</org_study_id>
    <nct_id>NCT02344368</nct_id>
  </id_info>
  <brief_title>The Effect of Sucrose on Pain Relief During Venous Blood Sampling in Preterm Infants</brief_title>
  <official_title>The Effect of Sucrose on Pain Relief During Venous Blood Sampling in Preterm Infants: a Comparison of Two Different Doses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lower Umfolozi Regional War Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite the fact that oral sucrose is the most frequently studied non-pharmacological
      intervention for procedural pain relief in infants, there is a paucity of data on the
      minimal effective dose. The aim of this study is to find the minimal effective dose of
      sucrose to reduce pain during a single venous blood sampling procedure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain</measure>
    <time_frame>1 week</time_frame>
    <description>assessed by Premature Infant Pain Profile-Revised (PIPP-R). Pain score related to the blood sampling will be performed two times: at skin puncture and immediately after the needle has been removed</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>0.2 ml sucrose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>on 2 occasions within 1 week 0.2 ml sucrose 25% or 0.5 ml sucrose 25% will be given in randomized order to the same infant during blood sampling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.5 ml sucrose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>on 2 occasions within 1 week 0.2 ml sucrose 25% or 0.5 ml sucrose 25% will be given in randomized order to the same infant during blood sampling</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>0.2 ml sucrose 25%</intervention_name>
    <description>Administered on the tongue by a syringe, a half dose two minutes before blood sampling and the other half dose immediately before sampling</description>
    <arm_group_label>0.2 ml sucrose</arm_group_label>
    <arm_group_label>0.5 ml sucrose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>0.5 ml sucrose 25%</intervention_name>
    <description>Administered on the tongue by a syringe, a half dose two minutes before blood sampling and the other half dose immediately before sampling</description>
    <arm_group_label>0.2 ml sucrose</arm_group_label>
    <arm_group_label>0.5 ml sucrose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  born preterm

          -  more than 1000 gram

        Exclusion Criteria:

          -  severe intraventricular hemorrhage

          -  cerebral malformations

          -  other malformations requiring surgery

          -  medication that may impair pain expression (opioids, paracetamol, sedatives)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>8 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>HÃ¥kon Bergseng, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St Olavs Hospital</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lower Umfolozi Rigional War Memorial Hospital, NICU</name>
      <address>
        <city>Empangeni</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
    <country>South Africa</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>July 15, 2016</lastchanged_date>
  <firstreceived_date>January 16, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sucrose</keyword>
  <keyword>Anesthesia</keyword>
  <keyword>Blood specimen collection</keyword>
  <keyword>Injections, Intravenous</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
